Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 772 is a member of the C2H2-type zinc finger transcription factor family, which is among the most abundant DNA-binding proteins in eukaryotes[1][3][5]. ZNF772 functions in the nucleus and is thought to regulate gene expression by binding to specific DNA sequences, modulating transcription via RNA polymerase II[3][5][9][11]. It is not generally targeted by drugs and has no established role as a therapeutic target. Disease association data suggest links to certain cancers (notably prostate cancer), but mechanistic or clinical significance remains limited or unclear[5][9][11]. The protein belongs to a structurally diverse group whose roles, although primarily related to gene regulation, may extend to other processes including apoptosis, though specific functional data for ZNF772 remain sparse[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 772 (ZNF772).